Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells
about
Current advances in Phi29 pRNA biology and its application in drug deliveryCrystal structure of 3WJ core revealing divalent ion-promoted thermostability and assembly of the Phi29 hexameric motor pRNATargeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNAIn Silico, In Vitro, and In Vivo Studies Indicate the Potential Use of Bolaamphiphiles for Therapeutic siRNAs DeliveryInhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs.Aptamers: current challenges and future prospects.RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Uniqueness, advantages, challenges, solutions, and perspectives in therapeutics applying RNA nanotechnology.Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration.Current progress of RNA aptamer-based therapeutics.Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicineRNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applicationsActivation of different split functionalities on re-association of RNA-DNA hybridsTwins, quadruplexes, and more: functional aspects of native and engineered RNA self-assembly in vivoRNA nanotechnology for computer design and in vivo computation.Aptamer-based therapeutics: new approaches to combat human viral diseasesStable RNA nanoparticles as potential new generation drugs for cancer therapy.Thermodynamic stabilities of three-way junction nanomotifs in prohead RNA.Ultrastable pRNA hexameric ring gearing hexameric phi29 DNA-packaging motor by revolving without rotating and coiling.Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.Entropy-driven one-step formation of Phi29 pRNA 3WJ from three RNA fragments.Nanolayered siRNA dressing for sustained localized knockdown.Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.Mechanism of three-component collision to produce ultrastable pRNA three-way junction of Phi29 DNA-packaging motor by kinetic assessment.Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan.Physicochemically tunable polyfunctionalized RNA square architecture with fluorogenic and ribozymatic properties.RNA nanoparticles come of age.RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery.RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.Isothermal folding of a light-up bio-orthogonal RNA origami nanoribbon.
P2860
Q26828745-21B08993-30F7-46C1-9DB3-FF287E61CB89Q27679196-4CF61531-13EB-4745-AAC5-4A2700DACF14Q28478596-DA915920-4837-4795-A28C-A598363058C0Q30538383-D124CFC6-737C-4500-9144-D3EFE94DB7F4Q34456173-2DD2374B-3BC0-42DA-A3EA-B38AEA900DDBQ35859041-03DCBEBC-1EEE-439E-92FB-1A3106476596Q35866025-8614B9A8-C608-4780-9E59-8F56340645FBQ35963673-4BD71EF5-24BF-4AE3-ABAB-C16F71DE8CDAQ36184758-C813C81F-2DD6-4C3C-B883-DBC6C0642939Q36185327-0A534433-7FB0-4730-AD71-79F4EBEB6D99Q36365202-23266A2D-44FE-489E-8D53-0BEF7EFBAD98Q36401727-BD8CAF69-46DE-4849-9286-B5D1A2701034Q36449335-99C1FA42-4D6D-4ACA-993C-882D76DA2B8BQ36745494-6E929DF2-7875-427A-974E-F7D523280FF2Q37051423-88B78679-6D2C-408A-A829-4AE1E08702BCQ37134622-2B52D3FC-BD5E-41AB-AD33-DA7DF242C343Q37415958-75241723-3143-4851-B9E7-FE9C41D666A0Q37640468-213445E0-BAB6-450A-9A37-4D23C25205FEQ37685647-A6122735-5B3C-4B4C-97EB-F65DFC583E95Q38107616-487B4736-48F8-429E-8903-B0EC9A0449C1Q38774730-1A695D0E-427C-4175-809B-D4DE2E2C7BEBQ39044626-F430D979-AEA2-4C57-845A-4E2C25E4A4B0Q39152253-8110288B-AED9-4FD3-B106-68548CF1FD79Q39162819-349506C9-6975-441B-983E-E3497F40B0A3Q40564594-38E8F0EC-D0E3-4F78-88BE-34443F6FE593Q41646988-98EB4A5B-30DB-4DDF-A99C-7FD09CE79BD2Q41885592-710B85E1-D4DA-404A-8539-97A5A720FD02Q42741740-9042F5CE-460E-4225-9348-479B5498D6FBQ49904261-0EDA6BEC-29A9-4A65-810F-243C3090E749Q50144632-B6AB6757-7E63-4A86-8F97-EB28231ED835Q54457076-BC1585BB-17E4-413A-B23C-09B041407722Q55308401-C29FCE06-1298-44D6-A77B-94EDF74F3F8D
P2860
Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assembly of multifunctional ph ...... therapeutics to targeted cells
@en
Assembly of multifunctional ph ...... herapeutics to targeted cells.
@nl
type
label
Assembly of multifunctional ph ...... therapeutics to targeted cells
@en
Assembly of multifunctional ph ...... herapeutics to targeted cells.
@nl
prefLabel
Assembly of multifunctional ph ...... therapeutics to targeted cells
@en
Assembly of multifunctional ph ...... herapeutics to targeted cells.
@nl
P2093
P2860
P1433
P1476
Assembly of multifunctional ph ...... therapeutics to targeted cells
@en
P2093
P2860
P304
P356
10.1016/J.YMETH.2011.01.008
P577
2011-02-12T00:00:00Z